COVID-19 clinical implications: the significance of nanomedicine

Jaleh Barar ^1,2 *

Cited by CrossRef: 7

1- Speth R. An opinion on the impacts of COVID-19 worldwide. Bioimpacts. 2022;12(3):293 [Crossref]

2- Rahman M, Ahmed M, Islam M, Khan M, Sultana S, Maeesa S, Hasan S, Hossain M, Ferdous K, Mathew B, Rauf A, Uddin M. Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19. CPD. 2022;28(12):948 [Crossref]

3- Albaz A, Rafeeq M, Sain Z, Almutairi W, Alamri A, Aloufi A, Almalki W, Tarique M. Nanotechnology-based approaches in the fight against SARS-CoV-2. AIMSMICRO. 2021;7(4):368 [Crossref]

4- Vahedifard F, Chakravarthy K. Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19. emergent mater. 2021;4(1):75 [Crossref]

5- Varahachalam S, Lahooti B, Chamaneh M, Bagchi S, Chhibber T, Morris K, Bolanos J, Kim N, Kaushik A. Nanomedicine for the SARS-CoV-2: State-of-the-Art and Future Prospects. IJN. 2021;Volume 16:539 [Crossref]

6- Zhu W, Wei Z, Han C, Weng X. Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment. Nanomaterials. 2021;11(12):3346 [Crossref]

7- Wang Y, Hao Y, Fa S, Zheng W, Yuan C, Wang W. Nanomedicine for the Diagnosis and Therapy of COVID-19. Front Bioeng Biotechnol. 2021;9 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons